Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Acarbose). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Renabos এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
The recommended starting dose of Acarbose is 25 mg taken by mouth three times a day, with the first bite of each main meal. Some patients, however, may do better with a more gradual increase in dose to help reduce stomach and gut side effects. This can be done by starting treatment at 25 mg once a day and then slowly increasing how often it is taken until a dose of 25 mg three times a day is reached. Maintenance Dosage Once a dosage of 25 mg three times a day has been reached, the dose of Acarbose should be adjusted every 4 to 8 weeks based on one-hour after-meal blood glucose levels or glycosylated hemoglobin levels, as well as how well the patient tolerates the medicine. The dose can be raised from 25 mg three times a day to 50 mg three times a day. Some patients may benefit from a further increase to 100 mg three times a day. The usual maintenance dose ranges from 50 mg three times a day to 100 mg three times a day.
পার্শ্বপ্রতিক্রিয়া
Diarrhea, gas, upset stomach, constipation, or stomach discomfort can occur during the first few weeks as your body gets used to this medicine, and these effects usually ease with time. Sticking to your prescribed diet can help reduce them. If any of these symptoms continue or become worse, let your doctor or pharmacist know right away.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Because of how it works, Acaril taken on its own should not cause hypoglycemia while fasting or after meals. Sulfonylurea medicines or insulin, on the other hand, can cause hypoglycemia, and if Acaril is combined with either of these, blood glucose may be lowered further, raising the potential for hypoglycemia. Hypoglycemia does not normally occur in patients taking metformin alone, and adding Acaril to metformin therapy was not found to increase its incidence. If mild to moderate hypoglycemia needs to be treated, oral glucose (dextrose) should be used rather than sucrose (cane sugar), since Acaril does not inhibit the absorption of glucose. Sucrose is unsuitable for correcting hypoglycemia quickly, because Acaril inhibits its breakdown into glucose and fructose. Severe hypoglycemia may need to be treated with an intravenous glucose infusion or a glucagon injection.
নিষেধাজ্ঞা
Acarbose is contraindicated in patients with known hypersensitivity to the drug. Precose is contraindicated in patients with diabetic ketoacidosis or cirrhosis. Acarbose is also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. In addition, Acarbose is contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.